Similar articles

• [Biochemical markers of bone remodeling in the prevention of postmenopausal osteoporosis].

  Calleri L, Porcelli A, Surico N. Calleri L, et al. Minerva Ginecol. 1998 Oct;50(10):423-8. Minerva Ginecol. 1998. PMID: 9866953 Review. Italian.
• Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients.

  Recker R, Lappe J, Davies KM, Heaney R. Recker R, et al. J Bone Miner Res. 2004 Oct;19(10):1628-33. doi: 10.1359/JBMR.040710. Epub 2004 Jul 21. J Bone Miner Res. 2004. PMID: 15355557
• Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis.

  Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ. Dalle Carbonare L, et al. J Bone Miner Res. 2001 Jan;16(1):97-103. doi: 10.1359/jbmr.2001.16.1.97. J Bone Miner Res. 2001. PMID: 11149495
• Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters.

  Arlot M, Meunier PJ, Boivin G, Haddock L, Tamayo J, Correa-Rotter R, Jasqui S, Donley DW, Dalsky GP, Martin JS, Eriksen EF. Arlot M, et al. J Bone Miner Res. 2005 Jul;20(7):1244-53. doi: 10.1359/JBMR.050309. Epub 2005 Mar 14. J Bone Miner Res. 2005. PMID: 15940379 Clinical Trial.
• Biochemical markers of bone turnover in osteoporosis.

  Delmas PD, Beaudreuil J. Delmas PD, et al. Rev Rhum Engl Ed. 1997 Jun 30;64(6 Suppl):31S-36S. Rev Rhum Engl Ed. 1997. PMID: 9273935 Review. No abstract available.